Up 377% since March: Is the Mesoblast share price a buy?

The Mesoblast Limited (ASX: MSB) share price has been a big success story in 2020. The Mesoblast share price has now rocketed 377.5% higher since bottoming at $1.02 per share in the March bear market.
What does Mesoblast do?
Mesoblast is a leading Aussie biotech company that specialises in regenerative medicine. 
The company has a number of innovative cellular medicines to treat serious and life-threatening diseases.
Specifically, Mesoblast seeks to provide treatments for inflammatory ailmen…

Click here to view the original article.